&nbsp;

YVM-Poster-Tabloid-Size-Web-French.pdf

Nov 2023

Document

YVM-Poster-Letter-Size-Print-English.pdf

Nov 2023

Document

YVM-Poster-Letter-Size-Print-French.pdf

Nov 2023

Document

YVM-Poster-Tabloid-Size-Web-English.pdf

Nov 2023

Document

YVM-Poster-Letter-Size-Web-English.pdf

Nov 2023

Document

YVM-Poster-Letter-Size-Web-French.pdf

Nov 2023

Regimen

GLOF; GLOF(RAMP)

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's High Grade,

Lymphoma - Non-Hodgkin's Intermediate Grade

Intent: Palliative

Funding:

New Drug Funding Program

Glofitamab (Outpatient) - Relapsed or Refractory Diffuse Large B-cell Lymphoma

High Cost Therapy Funding Program

Glofitamab (Inpatient) - Relapsed or Refractory Diffuse Large B-cell Lymphoma

, Collapse Show fewer tags

Drugs Used:

oBINutuzumab,

glofitamab

... Show more tags

Quick Link(s):

Regimen Monograph

Sep 2024

Regimen

GEMC+RAMU

Cancer Type:

Lung,

Mesothelioma (Pleural)

, Collapse Show fewer tags

Intent: Palliative

Drugs Used:

ramucirumab (Unfunded),

gemcitabine

... Show more tags

Quick Link(s):

Regimen Monograph

Oct 2024

Gestion de votre anxiété

Imprimer Ce guide destiné aux patients vous aidera à comprendre ce qui suit : Qu’est-ce que l’anxiété? Quelles peuvent être les sources d’...

Regimen

GEMC+PEMB(MNT)

Cancer Type:

Gastrointestinal,

Hepatobiliary / Liver / Bile Duct

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - Locally Advanced Unresectable or Metastatic Biliary Tract Cancer